Retatrutide
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist. A single peptide with agonist activity at three receptors: GIP, GLP-1 and glucagon. The glucagon component is what distinguishes it from dual agonists such as tirzepatide.
Class and mechanism
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist. A single peptide with agonist activity at three receptors: GIP, GLP-1 and glucagon. The glucagon component is what distinguishes it from dual agonists such as tirzepatide.
How it is supplied
Retatrutide is supplied as a lyophilised vial, or pre-filled pen graduated in dial units. Reported half-life: Long, supporting weekly intervals in clinical study design. Storage: Refrigerated. Pens must not be frozen. Protect from light.
| Listing | Strength | Price | Cost per mg | Stock |
|---|---|---|---|---|
| Quanta Pharma Retatrutide 30mg + Free BW | 30 mg | £160 | £5.33 per mg | in stock |
| SerenQ Retatrutide Pen | - | £210 | - | in stock |
| VLS Retatrutide Pen | - | £220 | - | in stock |
| Quanta Pharma Retatrutide 50mg + Free BW | 50 mg | £225 | £4.50 per mg | in stock |
Quanta Pharma Retatrutide 30mg + Free BWin stock£160- SerenQ Retatrutide Penin stock£210
VLS Retatrutide Penin stock£220
Quanta Pharma Retatrutide 50mg + Free BWin stock£225
Availability checked 2026-09-08. The product page carries live stock.